Pascolizumab
   HOME

TheInfoList



OR:

Pascolizumab is a humanized monoclonal antibody for the treatment of
asthma Asthma is a common long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and easily triggered bronchospasms. Symptoms include episodes of wh ...
. A Phase II
clinical trial Clinical trials are prospective biomedical or behavioral research studies on human subject research, human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel v ...
in patients with symptomatic
glucocorticoid Glucocorticoids (or, less commonly, glucocorticosteroids) are a class of corticosteroids, which are a class of steroid hormones. Glucocorticoids are corticosteroids that bind to the glucocorticoid receptor that is present in almost every vertebra ...
naive asthma was conducted in 2001/2002. Development was discontinued as it showed little benefit.


References

Monoclonal antibodies Experimental monoclonal antibodies {{antineoplastic-drug-stub